Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Dividend Declaration

6 Feb 2024 11:07

RNS Number : 1954C
Maven Income and Growth VCT 3 PLC
06 February 2024
 

 

Maven Income and Growth VCT 3 PLC

 

Proposed Final Dividend

 

On 18 December 2023, the Directors of Maven Income and Growth VCT 3 PLC ("the Company") announced that the unaudited net asset value of the Company as at 30 November 2023 was 52.48p per Ordinary Share.

 

The Directors propose that a final dividend of 2.15p per Ordinary Share, in respect of the year ended 30 November 2023, be paid on 3 May 2024 to Shareholders on the register at close of business on 22 March 2024.

 

As Shareholders will be aware from recent Annual and Interim Reports, decisions on distributions take into consideration a number of factors, including the availability of surplus revenue, the realisation of capital gains, the adequacy of distributable reserves and the VCT qualifying level. The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the conditions set out above, will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the immediately preceding year end. This final dividend will bring total distributions for the financial year to 2.65p per Ordinary Share, representing an annual yield of 4.62%.

 

Since the Company's launch, and after receipt of this final dividend, a total of 99.72p per share will have been distributed in tax-free dividends. It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

 

Dividend Investment Scheme

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances. Terms & conditions of the scheme, together with a mandate form, are available from the Company's webpage at: mavencp.com/migvct3.

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 3 May 2024, should ensure that a mandate form is received by the Company's Registrar, The City Partnership (UK) Limited, prior to the dividend election date of 12 April 2024. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 30 November 2023 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

6 February 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAFAKEELLEFA
Date   Source Headline
31st Jul 20143:06 pmRNSDirector/PDMR Shareholding
31st Jul 20143:03 pmRNSTransaction in Own Shares
29th Jul 20143:44 pmRNSDirector/PDMR Shareholding
29th Jul 201412:37 pmRNSHalf Yearly Report
4th Jul 20144:31 pmRNSReplacement re Issue of Equity
2nd Jul 20149:50 amRNSIssue of Equity
28th May 20145:09 pmRNSOffer for Subscription Update
30th Apr 20142:25 pmRNSDirectorate Change
30th Apr 20142:18 pmRNSAGM Results
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:46 pmRNSOffer for Subscription - Supplementary Prospectus
15th Apr 201410:09 amRNSInterim Management Statement
7th Apr 20144:16 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:29 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
4th Mar 20143:56 pmRNSAnnual Financial Report
13th Feb 201410:42 amRNSDirector/PDMR Shareholding
10th Feb 20146:05 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:20 pmRNSIssue of Equity
3rd Jan 201411:09 amRNSDirectorate Change
27th Nov 20132:04 pmRNSReplacement Result of General Meeting
27th Nov 20131:33 pmRNSResult of EGM
24th Oct 20136:11 pmRNSOffer for Subscription
17th Oct 20132:39 pmRNSInterim Management Statement
25th Sep 201311:33 amRNSStatement re Proposed Joint Fund Raising
30th Aug 20133:34 pmRNSTransaction in Own Shares
29th Aug 20134:11 pmRNSTransaction in Own Shares
27th Aug 20133:56 pmRNSTransaction in Own Shares
23rd Aug 201312:42 pmRNSTransaction in Own Shares
22nd Aug 20133:07 pmRNSTransaction in Own Shares
20th Aug 20132:59 pmRNSTransaction in Own Shares
16th Aug 20132:53 pmRNSTransaction in Own Shares
15th Aug 20133:07 pmRNSTransaction in Own Shares
12th Aug 20131:21 pmRNSTransaction in Own Shares
15th Jul 20134:32 pmRNSHalf Yearly Report
18th Jun 20132:22 pmRNSChange of Registered Office
10th May 20135:59 pmRNSTransaction in Own Shares
7th May 20134:24 pmRNSTransaction in Own Shares
2nd May 20135:18 pmRNSDirector/PDMR Shareholding
2nd May 20135:16 pmRNSDirector/PDMR Shareholding
2nd May 20135:10 pmRNSDirector/PDMR Shareholding
2nd May 20135:04 pmRNSInterim Management Statement
1st May 20133:21 pmRNSResult of AGM
26th Apr 20132:57 pmRNSIssue of Equity
10th Apr 20133:11 pmRNSTransaction in Own Shares
9th Apr 201312:47 pmRNSTransaction in Own Shares
8th Apr 20131:52 pmRNSTransaction in Own Shares
8th Apr 20137:00 amRNSIssue of Equity
5th Apr 20136:14 pmRNSIssue of Equity
5th Apr 20134:54 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.